newsfilter
← Latest News
PR Newswire·

ALHC Investor Notification: Alignment Healthcare Investigated for Securities Fraud on behalf of Investors with Losses after Inflated EBITDA Leads to 16% Stock Drop

  • Bleichmar Fonti & Auld LLP is investigating Alignment Healthcare, Inc. for potential securities fraud.
  • The investigation focuses on allegations that the company & its executives artificially inflated adjusted EBITDA to increase executive compensation.
  • Former chief technology officer filed a whistleblower lawsuit alleging $8 million to $10 million in routine operating expenses were misclassified as capital expenditures.
  • These misclassifications allegedly enabled Alignment to report $1.3 million in positive adjusted EBITDA for 2024 instead of a loss between $7 million & $9 million.
  • Alignment shares fell 16.7% on July 8, 2026, following the whistleblower allegations.
  • Alignment operates a platform managing Medicare Advantage plans as a healthcare services company.
  • BFA Law offers representation on a contingency fee basis with no cost to shareholders.
  • Shareholders are encouraged to submit information via the BFA Law website to discuss legal options.
Company
Bleichmar Fonti & Auld LLP
Keywords
Bleichmar Fonti & Auld LLP